Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 39.89% is 28% below its 5-year average of 55.35%, near the low end of its 5-year range (39.89%–68.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.58% below its 12-month average of 43.16%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 39.89%.
DEBT TO ASSETS RATIO
39.89%
DEBT TO ASSETS RATIO AVG TTM
43.16%
DEBT TO ASSETS RATIO AVG 3Y
46.54%
DEBT TO ASSETS RATIO AVG 5Y
55.35%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.58%
CURRENT VS 3Y AVG
-14.29%
CURRENT VS 5Y AVG
-27.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.12%
median of 401 covered companies
CURRENT VS SECTOR MEDIAN
+33140.95%
vs the sector median at left
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Debt to Assets Ratio
39.89%
TTM Avg
43.16%
3Y Avg
46.54%
5Y Avg
55.35%
Market Cap
$12.00B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.52B
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.85B
Debt to Assets Ratio
0.83%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.89B
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.95B
Debt to Assets Ratio
2.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.36B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 39.89% | 43.16% | 46.54% | 55.35% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 0.38% | N/A | N/A | N/A |
| Penumbra, Inc. (PEN)vs › | $12.49B | 0.11% | N/A | N/A | N/A |
| Baxter International Inc. (BAX)vs › | $12.52B | 0.49% | N/A | N/A | N/A |
| Halozyme Therapeutics, Inc. (HALO)vs › | $12.85B | 0.83% | N/A | N/A | N/A |
| DaVita Inc. (DVA)vs › | $11.47B | 0.61% | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.21% | N/A | N/A | N/A |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 2.05% | N/A | N/A | N/A |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 0.11% | N/A | N/A | N/A |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.01% | N/A | N/A | N/A |
Debt/Assets
39.9%
Debt/Equity
1.17
Current Ratio
1.59
Interest Coverage
1.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 39.89% |
| 2026-03-31 | 43.45% |
| 2025-12-31 | 42.21% |
| 2025-09-30 | 44.62% |
| 2025-06-30 | 45.63% |
| 2025-03-31 | 46.47% |
| 2024-12-31 | 49.02% |
| 2024-09-30 | 51.17% |
| 2024-06-30 | 51.95% |
| 2024-03-31 | 51.02% |
| 2023-12-31 | 66.34% |
| 2023-09-30 | 68.76% |
| 2023-06-30 | 68.51% |
| 2022-12-31 | 67.58% |
| 2021-12-31 | 68.39% |
| 2021-09-30 | 67.63% |
| 2021-06-30 | 68.34% |
| 2021-03-31 | 68.34% |
| 2020-12-31 | 65.50% |
| 2019-12-31 | 60.92% |
